The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression
Abstract
Amyotrophic lateral sclerosis is a typically rapidly progressive neurodegenerative disorder affecting motor neurons leading to progressive muscle paralysis and death, usually from respiratory failure, in 3-5 years. Some patients have slow disease progression and prolonged survival, but the underlying mechanisms remain poorly understood. Riluzole, the only approved treatment, only modestly prolongs survival and has no effect on muscle function. In the early phase of the disease, motor neuron loss is initially compensated for by collateral reinnervation, but over time this compensation fails, leading to progressive muscle wasting. The crucial role of muscle histone deacetylase 4 and its regulator microRNA-206 in compensatory reinnervation and disease progression was recently suggested in a mouse model of amyotrophic lateral sclerosis (transgenic mice carrying human mutations in the superoxide dismutase gene). Here, we sought to investigate whether the microRNA-206-histone deacetylase 4 pathway plays a role in muscle compensatory reinnervation in patients with amyotrophic lateral sclerosis and thus contributes to disease outcome differences. We studied muscle reinnervation using high-resolution confocal imaging of neuromuscular junctions in muscle samples obtained from 11 patients with amyotrophic lateral sclerosis, including five long-term survivors. We showed that the proportion of reinnervated neuromuscular junctions was significantly higher in long-term survivors than in pat…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miRNAs are increasingly recognized as key regulators in ALS pathophysiology, including mitochondrial integrity and neuroinflammation, with miR-155 and miR-206 demonstrating pivotal roles in SOD1G93A models [48,49,50,51].”
From Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis (2026) · cites this paper as [51]
Citations
Cites
Plum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,364
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Data on the distribution of fibre types in thirty-six human muscles
Johnson, M. A., Polgar, J., Weightman, D., & Appleton, D. (1973) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(73)90023-3 · Cited by 2,200
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Self-citationA Histochemical Method for Localizing Cholinesterase Activity.
Koelle, G. B., & Friedenwald, J. S. (1949) · Experimental Biology and Medicine · doi:10.3181/00379727-70-17013 · Cited by 1,185
Skeletal Muscle Adaptability: Significance for Metabolism and Performance
Saltin, B., & Gollnick, P. D. (1983) · Comprehensive Physiology · doi:10.1002/cphy.cp100119 · Cited by 890
Frey, D., Schneider, C., Xu, L., Borg, J., Spooren, W., & Caroni, P. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-07-02534.2000 · Cited by 687
MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice
Williams, A. H., Valdez, G., Moresi, V., Qi, X., McAnally, J., Elliott, J. L., Bassel-Duby, R., Sanes, J. R., & Olson, E. N. (2009) · Science · doi:10.1126/science.1181046 · Cited by 673
Pun, S., Santos, A. F., Saxena, S., Xu, L., & Caroni, P. (2006) · Nature Neuroscience · doi:10.1038/nn1653 · Cited by 658
MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets
van Rooij, E., & Olson, E. N. (2007) · Journal of Clinical Investigation · doi:10.1172/jci33099 · Cited by 553
Charcot, J. M. (1869) · Medical Entomology and Zoology · Cited by 321
SOME COMMENTS ON THE HISTOCHEMICAL CHARACTERIZATION OF MUSCLE ADENOSINE TRIPHOSPHATASE
BROOKE, M. H., & KAISER, K. K. (1969) · Journal of Histochemistry & Cytochemistry · doi:10.1177/17.6.431 · Cited by 290
A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis
Schaefer, A. M., Sanes, J. R., & Lichtman, J. W. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20620 · Cited by 266
The Histone Deacetylase HDAC4 Connects Neural Activity to Muscle Transcriptional Reprogramming
Cohen, T. J., Waddell, D. S., Barrientos, T., Lu, Z., Feng, G., Cox, G. A., Bodine, S. C., & Yao, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706268200 · Cited by 193
Identification of an Agrin Mutation that Causes Congenital Myasthenia and Affects Synapse Function
Huzé, C., Bauché, S., Richard, P., Chevessier, F., Goillot, E., Gaudon, K., Ammar, A. B., Chaboud, A., Grosjean, I., Lecuyer, H.-A., et al. (2009) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2009.06.015 · Cited by 178
Self-citationProlonged survival in motor neuron disease: a descriptive study of the King's database 1990-2002
Turner, M. R. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.7.995 · Cited by 147
Neuromuscular transmission in amyotrophic lateral sclerosis
Maselli, R. A., Wollman, R. L., Leung, C. G., Distad, B. J., Palombi, S., Richman, D. P., Salazar‐Grueso, E. F., & Roos, R. P. (1993) · Muscle & Nerve · doi:10.1002/mus.880161109 · Cited by 130
A quantitative electrophysiological study of motor neurone disease.
Hansen, S. K., & BALLANTYNE, J. P. (1978) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.41.9.773 · Cited by 130
McGuire, V. M., & Nelson, L. M. (2005) · CRC Press eBooks · doi:10.1201/b14133-6 · Cited by 121
Yoo, Y.-E., & Ko, C. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.06.003 · Cited by 121
Bromberg, M. B., Forshew, D. A., Nau, K. L., et al. (1993) · Muscle & Nerve · doi:10.1002/mus.880161111 · Cited by 119
Cohen, T. J., Barrientos, T., Hartman, Z. C., Garvey, S. M., Cox, G. A., & Yao, T. (2008) · The FASEB Journal · doi:10.1096/fj.08-115931 · Cited by 88
Predictors of long survival in amyotrophic lateral sclerosis: A population-based study
Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Guerra, V., Samarelli, V., Lepore, V. L., Simone, I. L., Lamberti, P., Serlenga, L., et al. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.10.023 · Cited by 84
Muscle Gene Expression Is a Marker of Amyotrophic Lateral Sclerosis Severity
Pradat, P., Dubourg, O., de Tapia, M., Scala, F. D., Dupuis, L., Lenglet, T., Bruneteau, G., Salachas, F., Lacomblez, L., Corvol, J., et al. (2011) · Neurodegenerative Diseases · doi:10.1159/000329723 · Cited by 63
Self-citationMotor Unit Populations in Healthy and Diseased Muscles
McComas, A. J., Galea, V., & de Bruin, H. (1993) · Physical Therapy · doi:10.1093/ptj/73.12.868 · Cited by 62
A Mutation Causes MuSK Reduced Sensitivity to Agrin and Congenital Myasthenia
Ammar, A. B., Soltanzadeh, P., Bauché, S., Richard, P., Goillot, E., Herbst, R., Gaudon, K., Huzé, C., Schaeffer, L., Yamanashi, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053826 · Cited by 56
Self-citationGattenlöhner, S., Schneider‐Gold, C., Thamer, C., Klein, R., Roggendorf, W., Gohlke, F., Niethammer, C., Czub, S., Vincent, A. C., Müller–Hermelink, H., et al. (2002) · Brain · doi:10.1093/brain/awf136 · Cited by 52
Patients who survive 5 years or more with ALS in Olmsted County, 1925-2004
Mateen, F. J., Carone, M., & Sorenson, E. J. (2010) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.201251 · Cited by 52
Bozec, S. L., & Maton, B. (1987) · European Journal of Applied Physiology · doi:10.1007/bf00690904 · Cited by 44
Anconeus muscle: A human muscle preparation suitable for in‐vitro microelectrode studies
Maselli, R. A., Mass, D. P., Distad, B. J., & Richman, D. P. (1991) · Muscle & Nerve · doi:10.1002/mus.880141208 · Cited by 38
Weber, M., Neuwirth, C., Thierbach, J., Schweikert, K., Czapliński, A., Petersen, J. A., Jung, H. H., Birve, A., Marklund, S., & Andersen, P. M. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2011.241349 · Cited by 21
On the role of the 200-kDa neurofilament protein at the developing neuromuscular junction
Donahue, S. P., Wood, J. G., & ENGLISH, A. W. (1988) · Developmental Biology · doi:10.1016/0012-1606(88)90422-8 · Cited by 16
Morphologie de la jonction neuro-musculaire
Coërs, C. (1964) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 3
Research works printed but not linked: 1
- Cöers, 1964, Morphologie de la jonction neuromusculaire, Arch Biol (Liège), 75, 905
Cited by
Shukla, S., & Tekwani, B. L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00537 · Cited by 314
Rossaert, E., Pollari, E., Jaspers, T., Van Helleputte, L., Jarpe, M., Van Damme, P., De Bock, K., Moisse, M., & Van Den Bosch, L. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0750-2 · Cited by 93
Calió, M. L., Henriques, E., Siena, A., Bertoncini, C. R. A., Gil-Mohapel, J., & Rosenstock, T. R. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00679 · Cited by 64
Burg, T., Rossaert, E., Moisse, M., Van Damme, P., & Van Den Bosch, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222011224 · Cited by 50
Modulation of the miR-485-3p/PGC-1α Pathway by ASO-Loaded Nanoparticles Attenuates ALS Pathogenesis
Ryu, I. S., Ha, D.-I., Jung, Y.-J., Lee, H. J., Kim, I., Lim, Y. N., Min, H. S., Kim, S. H., Yoon, I., Cho, H.-J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020615 · Cited by 2
Metadata
- Authors
- Bruneteau, G., Simonet, T., Bauché, S., Mandjee, N., Malfatti, E., Girard, E., Tanguy, M.-L., Behin, A., Khiami, F., Sariali, E., Hell-Remy, C., Salachas, F., Pradat, P.-F., Fournier, E., Lacomblez, L., Koenig, J., Romero, N. B., Fontaine, B., Meininger, V., Schaeffer, L., & Hantaï, D.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-07-03
- Volume
- 136
- Issue
- 8
- Pages
- 2359-2368
- ISSN
- 1460-2156
- 0006-8950
- Cited by
- 131
- References
- 33
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.